Search Results

Galderma, the world’s largest independent dermatology company, announced that it has received antitrust clearance from the U.S. authorities and has completed the acquisition of ALASTIN Skincare®, Inc., a specialty aesthetics company dedicated to developing innovative and clinically-tested physician-dispensed skincare products.

Galderma to Acquire Award-winning ALASTIN Skincare ® Enhancing Its Integrated Dermatology Platform to Continue Delivering the Best Experience to Patients.

In a strategic move to streamline operations and harness the collective expertise of its team, Crown Laboratories, Inc., a leader in skin science for life, announced the consolidation of its Premium Skincare and Therapeutic business units into a single, robust Consumer Skincare Division.

ALASTIN Skincare, Inc. announced the first shipment of ALASTIN products into Canada via their partnership with AVARI Medical Ltd.

NovaBay ® Pharmaceuticals, Inc. , announces that the Company has entered into an agreement to sell its DERMAdoctor ® skincare business including all product inventory for approximately $1.0 million in cash.

ALASTIN Skincare ®, Inc. - a specialty aesthetics company dedicated to developing and marketing innovative, clinically-tested physician-dispensed skin care products, announces that the Unit

ALASTIN Skincare®, Inc., a specialty aesthetics company dedicated to developing and marketing innovative, clinically-tested physician-dispensed skin care products, is named the Fastest Growing Brand in the U.S Professional Skincare Market for the third year in a row by consulting and research firm Kline Group’s 2019 Professional Skin Care: U.S. Market Analysis and Opportunities report.

Dr. Samuel Lynch, DMD and DMSc, a serial biotechnology entrepreneur, has announced the launch of Lynch Regenerative Medicine, Inc., a new advanced biotherapeutics skincare company targeting unmet clinical needs in both the aesthetic and advanced wound care markets.

ALASTIN Skincare®, Inc. - a specialty aesthetics company dedicated to developing and marketing innovative, clinically-tested physician-dispensed skin care products, is pleased to announce the publication of a clinical study highlighting their most recent award-winning breakthrough product, INhance Post-Injection Serum with TriHex Technology®.

ALASTIN Skincare®, Inc., a specialty aesthetics company dedicated to developing and marketing innovative, clinically-tested physician-dispensed skin care products, announces the launch of their newest post-procedure innovation, INhance Post-Injection Serum with TriHex Technology®(Patented TriHex Technology®: U.S. Patent, No. 10,286,030)